Physician profile
Ruby G Gubat
NPI 1023229572
$1,794.34
in general payments reported to CMS, 2019-2025
12 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Clinical Nurse Specialist provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $848 · 2022: $171 · 2023: $59.08 · 2024: $298 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $823.19 | 2021-2025 | Mitraclip |
| Cordis US Corp. | $367.81 | 2024-2025 | Mynx Control, Mynx Control Venous |
| Medtronic, INC. | $184.43 | 2021-2022 | |
| Abiomed | $134.47 | 2025 | |
| Biosense Webster, INC. | $98.53 | 2024-2025 | Carto 3 |
| Boston Scientific Corporation | $64.79 | 2022-2025 | Farapulse |
| Acist Medical Systems, INC. | $30.30 | 2024 | |
| Haemonetics Corporation | $29.30 | 2025 | Teg6s Hemostasis System |
| Lantheus Medical Imaging, INC. | $18.45 | 2023 | Definity |
| Novartis Pharmaceuticals Corporation | $17.23 | 2023 | |
| W. L. Gore & Associates, INC. | $13.89 | 2022 | |
| Biotronik INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Gubat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.